Intravenous Thrombolysis in Patients With ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration.
Auteur(s) :
Altersberger, V. L. [Auteur]
Rusche, N. [Auteur]
Martinez-Majander, N. [Auteur]
Hametner, C. [Auteur]
Scheitz, J. F. [Auteur]
Henon, Hilde [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Dell'acqua, M. L. [Auteur]
Strambo, D. [Auteur]
Stolp, J. [Auteur]
Heldner, M. R. [Auteur]
Grisendi, I. [Auteur]
Jovanovic, D. R. [Auteur]
Bejot, Y. [Auteur]
Pezzini, A. [Auteur]
Leker, R. R. [Auteur]
Kägi, G. [Auteur]
Wegener, S. [Auteur]
Cereda, C. W. [Auteur]
Lindgren, E. [Auteur]
Ntaios, G. [Auteur]
Piot, I. [Auteur]
Polymeris, A. A. [Auteur]
Lyrer, P. A. [Auteur]
Räty, S. [Auteur]
Sibolt, G. [Auteur]
Tiainen, M. [Auteur]
Heyse, M. [Auteur]
Erdur, H. [Auteur]
Kaaouana, O. [Auteur]
Padjen, V. [Auteur]
Zedde, M. [Auteur]
Arnold, M. [Auteur]
Nederkoorn, P. J. [Auteur]
Michel, P. [Auteur]
Bigliardi, G. [Auteur]
Zini, A. [Auteur]
Cordonnier, Charlotte [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Nolte, C. H. [Auteur]
Ringleb, P. A. [Auteur]
Curtze, S. [Auteur]
Engelter, S. T. [Auteur]
Gensicke, Henrik [Auteur]
Département de neurologie - Department of neurology [Hôpital de Bâle]
Rusche, N. [Auteur]
Martinez-Majander, N. [Auteur]
Hametner, C. [Auteur]
Scheitz, J. F. [Auteur]
Henon, Hilde [Auteur]

Lille Neurosciences & Cognition (LilNCog) - U 1172
Dell'acqua, M. L. [Auteur]
Strambo, D. [Auteur]
Stolp, J. [Auteur]
Heldner, M. R. [Auteur]
Grisendi, I. [Auteur]
Jovanovic, D. R. [Auteur]
Bejot, Y. [Auteur]
Pezzini, A. [Auteur]
Leker, R. R. [Auteur]
Kägi, G. [Auteur]
Wegener, S. [Auteur]
Cereda, C. W. [Auteur]
Lindgren, E. [Auteur]
Ntaios, G. [Auteur]
Piot, I. [Auteur]
Polymeris, A. A. [Auteur]
Lyrer, P. A. [Auteur]
Räty, S. [Auteur]
Sibolt, G. [Auteur]
Tiainen, M. [Auteur]
Heyse, M. [Auteur]
Erdur, H. [Auteur]
Kaaouana, O. [Auteur]
Padjen, V. [Auteur]
Zedde, M. [Auteur]
Arnold, M. [Auteur]
Nederkoorn, P. J. [Auteur]
Michel, P. [Auteur]
Bigliardi, G. [Auteur]
Zini, A. [Auteur]
Cordonnier, Charlotte [Auteur]

Lille Neurosciences & Cognition (LilNCog) - U 1172
Nolte, C. H. [Auteur]
Ringleb, P. A. [Auteur]
Curtze, S. [Auteur]
Engelter, S. T. [Auteur]
Gensicke, Henrik [Auteur]
Département de neurologie - Department of neurology [Hôpital de Bâle]
Titre de la revue :
Stroke
Numéro :
53
Pagination :
3557–3563
Éditeur :
American Heart Association
Date de publication :
2022-10-19
ISSN :
1524-4628
Mot(s)-clé(s) :
aged
intracranial hemorrhage
ischemic stroke
registries
survivors
intracranial hemorrhage
ischemic stroke
registries
survivors
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Background:
The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely ...
Lire la suite >Background: The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely influence individual IVT treatment decisions. Using data from a large IVT registry, we aimed to provide more evidence on safety of IVT in the very elderly. Methods: In this prospective multicenter study from the TRISP (Thrombolysis in Ischemic Stroke Patients) registry, we compared patients ≥90 years with those <90 years using symptomatic intracranial hemorrhage (ECASS [European Cooperative Acute Stroke Study]-II criteria), death, and poor functional outcome in survivors (modified Rankin Scale score 3–5 for patients with prestroke modified Rankin Scale score ≤2 and modified Rankin Scale score 4–5 for patients prestroke modified Rankin Scale ≥3) at 3 months as outcomes. We calculated adjusted odds ratio with 95% CI using logistic regression models. Results: Of 16 974 eligible patients, 976 (5.7%) were ≥90 years. Patients ≥90 years had higher median National Institutes of Health Stroke Scale on admission (12 versus 8) and were more often dependent prior to the index stroke (prestroke modified Rankin Scale score of ≥3; 45.2% versus 7.4%). Occurrence of symptomatic intracranial hemorrhage (5.7% versus 4.4%, odds ratioadjusted 1.14 [0.83–1.57]) did not differ significantly between both groups. However, the probability of death (odds ratioadjusted 3.77 [3.14–4.53]) and poor functional outcome (odds ratioadjusted 2.63 [2.13–3.25]) was higher in patients aged ≥90 years. Results for the sample of centenarians (n=21) were similar. Conclusions: The probability of symptomatic intracranial hemorrhage after IVT in very elderly patients with stroke did not exceed that of their younger counterparts. The higher probability of death and poor functional outcome during follow-up in the very elderly seems not to be related to IVT treatment. Very high age itself should not be a reason to withhold IVT.Lire moins >
Lire la suite >Background: The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely influence individual IVT treatment decisions. Using data from a large IVT registry, we aimed to provide more evidence on safety of IVT in the very elderly. Methods: In this prospective multicenter study from the TRISP (Thrombolysis in Ischemic Stroke Patients) registry, we compared patients ≥90 years with those <90 years using symptomatic intracranial hemorrhage (ECASS [European Cooperative Acute Stroke Study]-II criteria), death, and poor functional outcome in survivors (modified Rankin Scale score 3–5 for patients with prestroke modified Rankin Scale score ≤2 and modified Rankin Scale score 4–5 for patients prestroke modified Rankin Scale ≥3) at 3 months as outcomes. We calculated adjusted odds ratio with 95% CI using logistic regression models. Results: Of 16 974 eligible patients, 976 (5.7%) were ≥90 years. Patients ≥90 years had higher median National Institutes of Health Stroke Scale on admission (12 versus 8) and were more often dependent prior to the index stroke (prestroke modified Rankin Scale score of ≥3; 45.2% versus 7.4%). Occurrence of symptomatic intracranial hemorrhage (5.7% versus 4.4%, odds ratioadjusted 1.14 [0.83–1.57]) did not differ significantly between both groups. However, the probability of death (odds ratioadjusted 3.77 [3.14–4.53]) and poor functional outcome (odds ratioadjusted 2.63 [2.13–3.25]) was higher in patients aged ≥90 years. Results for the sample of centenarians (n=21) were similar. Conclusions: The probability of symptomatic intracranial hemorrhage after IVT in very elderly patients with stroke did not exceed that of their younger counterparts. The higher probability of death and poor functional outcome during follow-up in the very elderly seems not to be related to IVT treatment. Very high age itself should not be a reason to withhold IVT.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Date de dépôt :
2024-01-16T00:32:23Z
2024-07-10T07:36:14Z
2024-07-10T07:36:14Z